Yamagata M, Kanematsu T, Matsumata T, Utsunomiya T, Ikeda Y, Sugimachi K
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Eur J Surg Oncol. 1992 Aug;18(4):379-82.
In order to select more effective drugs under hypoxia for the treatment of hepatocellular carcinoma, the cytotoxicity of antineoplastic agents for two hepatoma cell lines, PLC/PRF/5 and HuH-7, was examined under both oxygenated and hypoxic conditions. Mitomycin C was observed potentially to have enhanced cytotoxicity under hypoxic conditions for both hepatoma cell lines. Carboquone showed enhanced cytotoxicity under hypoxia for PLC/PRF/5 alone. On the other hand, there was no cytotoxic enhancement of adriamycin or cisplatin in either cell line. Thus, the sensitivity of tumour cells to the cytotoxic agents altered according to the conditions to which the tumour was exposed. The selection of the antineoplastic drugs for chemotherapy therefore should depend not only on the sensitivity of individual tumours to various drugs, but the alteration of the cytotoxicity of the drugs under certain conditions should also be carefully taken into account.
为了在缺氧条件下选择更有效的药物治疗肝细胞癌,研究了两种肝癌细胞系PLC/PRF/5和HuH-7在有氧和缺氧条件下抗肿瘤药物的细胞毒性。观察到丝裂霉素C在缺氧条件下对两种肝癌细胞系都可能具有增强的细胞毒性。卡波醌仅在缺氧条件下对PLC/PRF/5显示出增强的细胞毒性。另一方面,阿霉素或顺铂在两种细胞系中均未显示出细胞毒性增强。因此,肿瘤细胞对细胞毒性药物的敏感性会根据肿瘤所处的条件而改变。因此,化疗抗肿瘤药物的选择不仅应取决于个体肿瘤对各种药物的敏感性,还应仔细考虑药物在特定条件下细胞毒性的变化。